Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy STAAR Surgical Company stock

Own STAAR Surgical Company stock in just a few minutes.

STAAR Surgical Company is a medical instruments & supplies business based in the US. STAAR Surgical Company shares (STAA) are listed on the NASDAQ and all prices are listed in US Dollars. STAAR Surgical Company employs 575 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in STAAR Surgical Company

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – STAA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

STAAR Surgical Company share price

Use our graph to track the performance of STAA stocks over time.

STAAR Surgical Company shares at a glance

Information last updated 2021-04-23.
52-week range$34.41 - $135.00
50-day moving average $103.49
200-day moving average $90.03
Wall St. target price$119.00
PE ratio 1115
Dividend yield N/A (0%)
Earnings per share (TTM) $0.12

Buy STAAR Surgical Company shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy STAAR Surgical Company stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is STAAR Surgical Company under- or over-valued?

Valuing STAAR Surgical Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of STAAR Surgical Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

STAAR Surgical Company's P/E ratio

STAAR Surgical Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1115x. In other words, STAAR Surgical Company shares trade at around 1115x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

STAAR Surgical Company's EBITDA

STAAR Surgical Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $11 million.

The EBITDA is a measure of a STAAR Surgical Company's overall financial performance and is widely used to measure a its profitability.

STAAR Surgical Company financials

Revenue TTM $163.5 million
Operating margin TTM 4.83%
Gross profit TTM $119.6 million
Return on assets TTM 2.12%
Return on equity TTM 3.31%
Profit margin 3.62%
Book value $4.25
Market capitalisation $6.2 billion

TTM: trailing 12 months

Shorting STAAR Surgical Company shares

There are currently 2.5 million STAAR Surgical Company shares held short by investors – that's known as STAAR Surgical Company's "short interest". This figure is 29.1% up from 2.0 million last month.

There are a few different ways that this level of interest in shorting STAAR Surgical Company shares can be evaluated.

STAAR Surgical Company's "short interest ratio" (SIR)

STAAR Surgical Company's "short interest ratio" (SIR) is the quantity of STAAR Surgical Company shares currently shorted divided by the average quantity of STAAR Surgical Company shares traded daily (recently around 664646.05263158). STAAR Surgical Company's SIR currently stands at 3.8. In other words for every 100,000 STAAR Surgical Company shares traded daily on the market, roughly 3800 shares are currently held short.

However STAAR Surgical Company's short interest can also be evaluated against the total number of STAAR Surgical Company shares, or, against the total number of tradable STAAR Surgical Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case STAAR Surgical Company's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 STAAR Surgical Company shares in existence, roughly 50 shares are currently held short) or 0.0716% of the tradable shares (for every 100,000 tradable STAAR Surgical Company shares, roughly 72 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against STAAR Surgical Company.

Find out more about how you can short STAAR Surgical Company stock.

STAAR Surgical Company share dividends

We're not expecting STAAR Surgical Company to pay a dividend over the next 12 months.

Have STAAR Surgical Company's shares ever split?

STAAR Surgical Company's shares were split on a 1:2 basis on 17 May 1992. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your STAAR Surgical Company shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for STAAR Surgical Company shares which in turn could have impacted STAAR Surgical Company's share price.

STAAR Surgical Company share price volatility

Over the last 12 months, STAAR Surgical Company's shares have ranged in value from as little as $34.41 up to $135. A popular way to gauge a stock's volatility is its "beta".

STAA.US volatility(beta: 0.91)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while STAAR Surgical Company's is 0.9057. This would suggest that STAAR Surgical Company's shares are less volatile than average (for this exchange).

STAAR Surgical Company overview

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site